Therapeutic vaccine with irradiated fibroblasts from patients' skin that have been engineered to produce interleukin-2: Began a Phase I trial in 12 patients to

The Immune Response Corp. (IMNR) Product: Therapeutic vaccine with irradiated fibroblasts from patients' skin that have been engineered to produce interleukin-2, combined with irradiated tumor cells f...